These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 3373754)

  • 1. [Drug evaluation according to the rapidity of healing relapsing of peptic ulcers].
    Kimura K; Yoshida Y; Kasano T; Kihira K; uzuki T
    Nihon Rinsho; 1988 Jan; 46(1):187-91. PubMed ID: 3373754
    [No Abstract]   [Full Text] [Related]  

  • 2. [Drug therapy and therapeutic tactics in gastroduodenal ulcer].
    Grigor'ev PIa; Isakov VA; Iakovenko EP
    Ter Arkh; 1988; 60(8):118-26. PubMed ID: 2906485
    [No Abstract]   [Full Text] [Related]  

  • 3. [Drug treatment of peptic ulcer].
    Miagkova LP
    Ter Arkh; 1978; 50(10):39-45. PubMed ID: 360461
    [No Abstract]   [Full Text] [Related]  

  • 4. Current trends in the pharmacotherapy for peptic ulcer disease.
    Hixson LJ; Kelley CL; Jones WN; Tuohy CD
    Arch Intern Med; 1992 Apr; 152(4):726-32. PubMed ID: 1558429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A method of evaluating drug efficacy by statistical analysis of healing speed of peptic ulcer.
    Kimura K; Ido K; Taniguchi Y; Suzuki T; Yoshida Y; Kawano S; Tsuji S
    J Gastroenterol Hepatol; 1996 Oct; 11(10):916-21. PubMed ID: 8912127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Problems in the traditional pharmacotherapy and prevention of peptic ulcer].
    Ryss ES
    Ter Arkh; 1984; 56(9):106-10. PubMed ID: 6393409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical evaluation of lansoprazole in the treatment of peptic ulcers: initial healing and prevention of relapse. Tohoku Peptic Ulcer Study Group.
    Asaki S; Sato A; Sakurada H; Takeda T; Hongo M; Toyota T
    J Clin Gastroenterol; 1995; 20 Suppl 2():S56-8. PubMed ID: 7594342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Ulcer-healing effect of alanton].
    Luchkova MM
    Ter Arkh; 1978; 50(1):37-8. PubMed ID: 635794
    [No Abstract]   [Full Text] [Related]  

  • 9. [Healing peptic ulcer disease with therapy of Helicobacter pylori infection--an overview].
    Leodolter A; Peitz U; Malfertheiner P
    Wien Med Wochenschr; 2001; 151(13-14):300-8. PubMed ID: 11582994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Follow-up survey of a large-scale multicenter, double-blind study of triple therapy with lansoprazole, amoxicillin, and clarithromycin for eradication of Helicobacter pylori in Japanese peptic ulcer patients.
    Asaka M; Kato M; Sugiyama T; Satoh K; Kuwayama H; Fukuda Y; Fujioka T; Takemoto T; Kimura K; Shimoyama T; Shimizu K; Kobayashi S;
    J Gastroenterol; 2003; 38(4):339-47. PubMed ID: 12743773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Some aspects of the critical evaluation of peptic ulcer therapy in patients.
    Mózsik G; Bertelli A; Deak G; Nagy L; Patty I; Simon L; Tárnok F; Jávor T
    Int J Clin Pharmacol Res; 1985; 5(6):447-55. PubMed ID: 4093220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug therapy of peptic ulcer disease.
    Ching CK; Lam SK
    Br J Hosp Med; 1995 Jul 12-Aug 15; 54(2-3):101-6. PubMed ID: 7551483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medical treatment of peptic ulcers.
    Deveney CW; Deveney KE
    Surg Annu; 1985; 17():219-33. PubMed ID: 3883541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topically active drugs in the treatment of peptic ulcers. Focus on colloidal bismuth subcitrate and sucralfate.
    Bianchi Porro G; Parente F
    J Clin Gastroenterol; 1992 Apr; 14(3):192-8. PubMed ID: 1348753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peptic ulcers in the elderly: unique features and management.
    Freston MS; Freston JW
    Geriatrics; 1990 Jan; 45(1):39-42, 45. PubMed ID: 2403956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peptic ulcer disease.
    Hawker P
    Practitioner; 1989 May; 233(1469):769-70, 773. PubMed ID: 2602318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of protective drugs in the prevention of ulcer relapse.
    Ota S; Terano A
    J Gastroenterol; 1994 Jul; 29 Suppl 7():139-40. PubMed ID: 7921147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of duodenal ulcer concomitant with successful Helicobacter pylori eradication.
    Pohle T; Hilker E; Domschke W
    Z Gastroenterol; 1997 Jul; 35(7):563-5. PubMed ID: 9273989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sucralfate and other non-antisecretory agents in the treatment of peptic ulcer disease.
    May B
    Methods Find Exp Clin Pharmacol; 1989; 11 Suppl 1():113-6. PubMed ID: 2657280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Long-term drug therapy of peptic ulcer disease. A current review of the status of various anti-ulcer drugs].
    Rohner HG; Rüther N
    Fortschr Med; 1986 Dec; 104(3):933-6. PubMed ID: 2881868
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.